Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics

Levodopa-carbidopa intestinal gel (LCIG, carbidopa-levodopa enteral suspension in the United States) is a treatment option for advanced Parkinson’s disease (PD) patients with motor fluctuations. The objective of this investigation was to identify the baseline characteristics predictive of treatment...

Full description

Saved in:
Bibliographic Details
Published in:NPJ Parkinsons Dis
Main Authors: Standaert, David G., Boyd, James T., Odin, Per, Robieson, Weining Z., Zamudio, Jorge, Chatamra, Krai
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5784118/
https://ncbi.nlm.nih.gov/pubmed/29387783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41531-017-0040-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items